Sangamo Therapeutics, Inc.’s SGMO share price has dipped by 5.89%, which has investors questioning if this is right time to ...

PTC Therapeutics, Inc.’s PTCT share price has surged by 6.72%, which has investors questioning if this is right time to sell.

A genetically engineered pig kidney helped Towana Looney enjoy 130 days without the need for dialysis before the organ was ...

BriaCell Therapeutics Corp. has a one year low of $3.00 and a one year high of $45.45. The business’s 50 day simple moving average is $4.19 and its two-hundred day simple moving average is $8.50.

In this article, we are going to take a look at where United Therapeutics Corporation (NASDAQ:UTHR) stands against other most profitable biotech stocks to buy right now. With improved market ...

United Therapeutics Corporation (Nasdaq: UTHR), a public benefit corporation, announced today that Great Place to Work® and Fortune magazine recognized the company as one of the Fortune 100 Best ...

Among the underlying components of the Russell 3000 index, we saw noteworthy options trading volume today in United Therapeutics ... history, with the $380 strike highlighted in orange: Atlassian ...

The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations ...

In this article, we are going to take a look at where United Therapeutics Corporation (NASDAQ:UTHR) stands against other most expensive stocks insiders are dumping in March. After being in the green ...

In a report released today, Edward Tenthoff from Piper Sandler reiterated a Buy rating on CAMP4 Therapeutics Corporation (CAMP – Research Report), with a price target of $18.00. The company’s ...